The KCA Awards Program supports kidney cancer investigators with research on disease biology, treatment vulnerabilities and lifestyle factors to improve care and guide future work.
The Chromophobe RCC Research Grant Award supports researchers studying a rare kidney cancer, funding innovative work shaped by patient priorities to generate preliminary data and pursue clinical impact.
Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants support researchers studying druggable targets and biomarkers to advance new kidney cancer treatments, diagnosis, monitoring, and prognosis.
Big-Nova Foundation Young Investigator Award supports early-career investigators conducting patient-oriented research to improve prevention, detection, prediction, or treatment of chronic kidney disease progression.
Young Investigator Awards support early-career investigators at NCCN Member Institutions, funding research in cancer biology, diagnosis, treatment, and care delivery to advance cancer care.